AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Niagen Bioscience, Inc. Director's Dealing 2015

Jul 13, 2015

32418_dirs_2015-07-13_c4bb6181-1ad6-40e9-9620-01d905a90554.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2015-07-09

Reporting Person: Fried Robert N (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	161000	Direct
Common Stock	38232	Indirect

Footnotes

F1: 20,232 shares held by Jeremy Fried and 18,000 shares held by Benjamin Fried, who are both sons of Robert Fried.